Works matching IS 1082801X AND DT 2004 AND VI 39 AND IP 12
Results: 18
Impact of counterfeit drugs on the formulary decision-making process.
- Published in:
- 2004
- By:
- Publication type:
- Journal Article
First-time generic approvals.
- Published in:
- Formulary, 2004, v. 39, n. 12, p. 571
- Publication type:
- Article
Selected literature.
- Published in:
- Formulary, 2004, v. 39, n. 12, p. 591
- Publication type:
- Article
Select cardiovascular agents.
- Published in:
- Formulary, 2004, v. 39, n. 12, p. 591
- Publication type:
- Article
Obesity initiative targets associated health risks, high medical costs.
- Published in:
- Formulary, 2004, v. 39, n. 12, p. 590
- Publication type:
- Article
New guidance for generic drugs clarifies protocol, increases speed to market.
- Published in:
- Formulary, 2004, v. 39, n. 12, p. 590
- Publication type:
- Article
Rofecoxib hearings point to failures in clinical testing design, decision-making transparency.
- Published in:
- Formulary, 2004, v. 39, n. 12, p. 589
- Publication type:
- Article
$139 million to advance information technology, records.
- Published in:
- Formulary, 2004, v. 39, n. 12, p. 588
- Publication type:
- Article
Government, industry provide pharmaceutical policy outlook for 2005 and beyond.
- Published in:
- Formulary, 2004, v. 39, n. 12, p. 588
- Publication type:
- Article
Valdecoxib meta-analysis finds increased cardiovascular risk.
- Published in:
- Formulary, 2004, v. 39, n. 12, p. 586
- Publication type:
- Article
Weekly nesiritide may have greatest benefit in highest-risk heart failure patients.
- Published in:
- Formulary, 2004, v. 39, n. 12, p. 585
- Publication type:
- Article
Safety labeling updates &new warnings.
- Published in:
- Formulary, 2004, v. 39, n. 12, p. 586
- Publication type:
- Article
Worldwide study finds that fluoroquinolones are still affective against CAP.
- Published in:
- Formulary, 2004, v. 39, n. 12, p. 584
- Publication type:
- Article
Pipeline preview.
- Published in:
- Formulary, 2004, v. 39, n. 12, p. 568
- Publication type:
- Article
New molecular entities.
- Published in:
- Formulary, 2004, v. 39, n. 12, p. 568
- Publication type:
- Article
Impact of counterfeit drugs on the formulary decision-making process.
- Published in:
- Formulary, 2004, v. 39, n. 12, p. 577
- By:
- Publication type:
- Article
A year of novel pharmacologic agents in review.
- Published in:
- Formulary, 2004, v. 39, n. 12, p. 572
- Publication type:
- Article
FDA actions in brief.
- Published in:
- Formulary, 2004, v. 39, n. 12, p. 571
- Publication type:
- Article